C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)[C@H](C)c2ccccc2)OCc2ccccc2-c2c(n(C)c3ccccc23)C1=O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?